Linked by Thom Holwerda on Fri 24th Jun 2011 22:46 UTC
Permalink for comment 478528
To read all comments associated with this story, please click here.
To read all comments associated with this story, please click here.
News
Linked by Thom Holwerda on 05/22/13 13:38 UTC
Linked by Thom Holwerda on 05/22/13 13:30 UTC, submitted by JRepin
Linked by Thom Holwerda on 05/21/13 22:06 UTC
Linked by Thom Holwerda on 05/21/13 21:45 UTC
Linked by Thom Holwerda on 05/21/13 15:53 UTC
Linked by Thom Holwerda on 05/20/13 22:43 UTC
Linked by Thom Holwerda on 05/20/13 21:50 UTC
Linked by Thom Holwerda on 05/19/13 23:15 UTC
Linked by Thom Holwerda on 05/19/13 23:11 UTC, submitted by Drumhellar
Linked by Thom Holwerda on 05/18/13 21:06 UTC
More News »
Sponsored Links



Member since:
2010-03-08
Well, that page which you provide has some good examples of what I'm meaning by "should they have the right?".
I'm personally happy that I can use the short and convenient "aspirin" instead of "acetylsalicylic acid", no matter who actually manufactures it. Excessive trademarking, on the other hand, tends to encourage putting lots of different names on the same thing. Like Doliprane, Efferalgan, etc... are all different trademarks on the same old paracetamol.
Question is : which would you prefer, given the choice ? Having the right to call every proprietary software repository "app store", or sticking with "proprietary software repository" as a generic name (which is as complicated as any generic name gets) and a myriad of trademarked names for the same thing ?